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Purpose: To synthesize hybrid benzimidazolyl-chalcone derivatives, evaluate their anthelmintic activity, 
and establish some structural elements which could lead to induction and enhancement of this activity. 
Methods: A series of 1-(1H-benzimidazol-2-yl)-3-aryl-2-propen-1-one compounds (6a-z) was 
synthesized by condensation reaction of 2-acetylbenzimidazole with aryl and heteroaryl aldehyde 
derivatives. The physicochemical characterization of these benzimidazolyl-chalcones was carried out by 




C NMR) and mass spectroscopy (MS). All 
compounds were screened in vitro for their nematicidal activity against Haemonchus contortus in larval 
development assay. The anthelmintic activities obtained were compared with those of anthelmintic 
reference drugs (fenbendazole and ivermectin); 1,3-diphenyl-2-propen-1-one also used as reference for 
chalcone.  
Results: Compounds 6a, 6g, 6w and 6y showed good nematicidal activity (LC100) at 0.002 and 0.0092 
µg/ml. The activity of these four benzimidazolyl-chalcones is nearly equal to that of fenbendazole. It is 
also interesting to know that these compounds have anti-haemonchus activity which is equal or more 
efficient than ivermectin. Four other compounds (6d, 6h, 6o and 6t) possess interesting anthelmintic 
activities at 0.68 and 0.16 µg/ml.  
Conclusion: Preliminary structure-activity relationship studies revealed that arylpropenone group in 
position 2 of the benzimidazole ring can be considered as new pharmacophore for nematicidal activity. 
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INTRODUCTION 
 
Nematodes as well as being the origin of 
most human parasitic diseases [1,2], remain 
the major cause of gastrointestinal infections 
and productivity loss of small ruminant 
livestock and pets [3,4]. This situation 
persists for two main reasons. The first is the 
poor veterinary coverage against 
Haemonchus contortus, the main 
gastrointestinal parasite of small ruminants 
[5]. The second reason is related to current 
misuse of anthelmintic compounds which 
engenders the occurrence of drug-resistant 
parasite strains [6-8]. Moreover, the 
discovery of a anthelmintic vaccine [9] 
constantly delayed by difficulties in drug 
development, has made the fight against 
parasites a major economic and food security 
issue. In this context, chemotherapy by 
developing new anthelmintic compounds 
which can circumvent the problems of drug 
resistance remains an essential weapon. This 
is why we have focused our investigations on 
the chemical series of chalcones and 
benzimidazoles. Chalcones or 1,3-diphenyl-
2-propen-1-ones are known for their multiple 
anti-infective activities including antimalarial, 
antileishmanial, antitrypanosomal, antibac-
terial, anti-tubercular, antifungal and antiviral 
[10,11]. The diversity of chalcones’ anti-
infective activity is due to the presence of 
enone moiety of which would cause an 
inhibitory mechanism of some enzymes with 
thiol function [12,13]. Moreover, appearance, 
orientation and optimization of biological 
properties of chalcones depend namely on 
three structural elements: integrity of enone 
moiety, nature of aryl rings (A and B) in 
position 1 and 3 in this functional group, 
nature and position of modulators R and R' 
on the aryl rings (Figure 1). As for the 
benzimidazole heterocyclic, it is an important 
vector of many anthelmintic drugs used in 
both human and veterinary medicine 
(albendazole, mebendazole, fenbendazole, 
triclabendazole, thiabendazole, etc) [14]. 
Despite the great diversity of chalcones 
biological activities, their anthelmintic 
properties especially their nematicidal activity 
against Haemonchus contortus, has not yet 
been described or known. Therefore, it 
seems logical to undertake chemical 
modulations around chalcones to guide their 
anti-infective properties toward nematicidal 
activities. We have, therefore, conceptualized 
a new hybrid chemical profile of chalcone and 
benzimidazole anthelmintic by juxtaposition 
of arylpropenone group and benzimidazole 
ring (Figure 1). The main objective of this 
work was to synthesize hybrid 







profile of chalcones or
1,3-diphenyl-2-propen-1-ones




















Figure 1: Conception and chemical profile of hybrid benzimidazolyl-chalcones (6a-z) 
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then evaluate their nematicidal activities in 
vitro against Haemonchus contortus. Another 
objective was to establish in this new 
chemical series, some structural elements 







The synthesis of benzimidazolyl-chalcones 
(6a-z) was made from 2-acetylbenzimidazole 
4 [15] (figure 2). This compound was 
obtained in two steps from o-
phenylenediamine 1. Indeed, condensation of 
1 with lactic acid 2 using Phillips method [16] 
has lead to 2-hydroxyethylbenzimidazole 3. 
Chromic oxidation of the latter followed by 
neutralization with ammonia led to 2-
acetylbenzimidazole in an overall yield of 
72%. This ketone was then condensed with 
aryl or heteroaryl aldehyde derivatives (5) 
using the Claisen-Schmidt reaction. The 
neutralization of the reaction mixture by dilute 
acetic acid followed by recrystallization gave, 
compounds 6a-z with yields ranging between 
50-86% (Figure 2). The general procedure for 
synthesis benzimidazolyl-chalcones is 
reported below. The chosen arylaldehyde (10 
mmol) was added to 2-acetylbenzimidazole 
(1.5 g, 10 mmol) in ethanol solution of sodium 
hydroxide (75 mmol sodium hydroxide in 40 
ml of ethanol). The reaction mixture was 
subsequently stirred at room temperature for 
5 h and neutralized with a solution of 30% 
acetic acid leading to a precipitate. It was 
filtered, dried and recrystallized in toluene or 
toluene/EtOH (4:1) to give compounds 6a-z. 
 
For all compounds 6a-z, melting points were 





C NMR spectra were 
measured on a Brucker Avance 300 
spectrometer. Chemical shifts (δ) are given in 
parts per million (ppm) relative to 
tetramethylsilane (TMS, δ = 0) used as 
internal reference in DMSO-d6; J values are 
given in hertz. Splitting patterns have been 
designated as follows: s, singlet; d, doublet; 
dd, double doublet; t, triplet; q, quartet; qt, 
quintuplet; m, multiplet. Mass spectra (MS) 
were recorded on a JEOL JMS DX300 
spectrometer in electrospray ionization mode 
(ESI mass). The thin layer chromatography 
(TLC) was performed on silica plates 
Macherey-Nagel Sil or alumina G/UV254 
Macherey-Nagel ALOX N/UV254. Solvents 
and reagents including arylaldehydes used 
































Figure 2: General procedure for preparing benzimidazolyl-chalcones 6a-z 
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Anthelmintic activity 
 
The method for determining anthelmintic 
activity or larval development assay required 
Haemonchus contortus eggs. Their 
preparation consists in an experimental 
infection of farmed sheep from 3000 to 6000 
infective larvae of Haemonchus contortus L3. 
After a period of 21 days, the faeces of sheep 
are infested with parasite eggs. A number of 
3000 eggs per gram of faeces has been 
considered reasonable to perform the 
anthelmintic tests. The eggs were extracted 
after grinding, filtration and centrifugation of 
faeces collected. The suspension was then 
adjusted with distilled water to a 
concentration of 80 eggs per 20 ml. The 
standard anthelmintic drugs (fenbendazole 
and ivermectin from Sigma Chemical Co, 
USA) and compounds 6a-z were provided as 
pure powder. The reference chalcone or 1,3-
diphenylpropenone was synthesized in our 
laboratory according to the classical Claisen-
Schmidt using acetophenone and 
benzaldehyde. All test compounds (6a-z) 
including anthelmintic standards drugs (7.5 
mg) were respectively dissolved in 1ml 
DMSO and diluted with distilled water to 
obtain a dilution series in 96 wells 
microtitration plates. Agar (l40 µL) at 45-50 
°C containing 2% amphotericin B was added 
to each well. In the prepared well, were 
added 80 eggs freshly harvested 
Haemonchus contortus. The microplates 
were kept at a humid atmosphere (90%) for 6 
days at 27° C. The normal larval 
development in the absence of test products 
was also performed in wells containing 
distilled water to serve as an experiment 
control. The number of hatched eggs and the 
number of larvae were counted; stages of 
development and mobility of larvae were 
recorded. For a development rate between 0 
and 5%, the test product was considered 
active. The tests were repeated three times 
with all compounds that showed nematicidal 
activity. The larvicidal concentration (LC100) 
determined, was the lowest concentration for 
which the normal larval development was 
completely blocked (no hatching eggs, 




We have synthesized and characterized 26 
hybrid benzimidazolyl-chalcone compounds 
6a-z. All synthesized compounds have in 
their respective molecule, the 1H-
benzimidazole heterocyclic and the 3-
aryl(heteroaryl)-2-propenone group. The aryl 
represented by phenyl ring was variously 
substituted by modulators such as alkyl, 
hydroxy, alkoxy, aminoalkyl halogen and 
nitro. As for heteroaryl rings, it’s pyridine and 
furan. The physicochemical results especially 
chemical groups characteristic (NH, -C=N, -
CO-CH=CH-) and ESI mass of all 
compounds 6a-z and their yields are reported 
below in table 1. Nematicidal activities of 
synthesized compounds were evaluated on 
eggs and larvae of Haemonchus contortus 
and then compared with the anthelmintic 
efficacy of anthelmintic standards drugs 
(fenbendazole and ivermectin). Also, to 
determine structural elements of nematicidal 
activity, we have evaluated the anthelmintic 
activity of 1,3-diphenylprop-2-en-1-one or 
standard chalcone. The results of 
anthelmintic tests (Table 1) showed that four 
compounds (6a, 6g, 6w and 6y) have good 
nematicidal activity (LC100) at 0.002 and 
0.0092 µg/ml. Four other compounds (6d, 6h, 
6o and 6t) possess interesting anthelmintic 
activities at 0.68 and 0.16 µg/ml. For the 
other compounds their nematicidal 
concentrations are lower and range from 




Analysis of our results (Table 1) in a 
preliminary structure-activity relationship 
studies, showed that the replacement of 
phenyl group (A) of standard chalcone or 1,3-
diphenylpropenone (Figure 1) by 2-
benzimidazolyl group, increased nematicidal 
activity against Haemonchus contortus. 
Indeed, compound 6a (LC100 = 0.002 µg/ml) 
was 6000 times more active than the 
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Table 1: Physicochemical data for characteristic groups and in vitro anthelmintic activity of compounds 6a-
















C NMR of NH, -C=N, -CO-CH=CH- (DMSO-







H: 14 (1H, s, NH); 8.28 (1H, d, J = 16 Hz, 
CH=CH); 8.15 (1H, d, J = 16 Hz, CH=CH).  
13
C: 181.13 (C=O); 149.49 (C=N); 143.97 








H: 13.54 (1H, s, NH); 8.20 (1H, d, J = 15.8 Hz, 
CH=CH); 8.06 (1H, d, J = 15.8 Hz, CH=CH).  
13
C: 180.89 (C=O); 149.02 (C=N); 144.30 





CH 3  
66 201-203 
1
H: 13.20 (1H, s, NH); 8.15 (1H, d, J = 15.6 Hz, 
CH=CH); 8.03 (1H, d, J = 15.6 Hz, CH=CH).  
13
C: 181.09 (C=O); 149.02 (C=N); 143.30 










H: 13.60 (1H, s, NH); 8.20 (1H, d, J = 15.8 Hz, 
CH=CH); 8.09 (1H, d, J = 15.8 Hz, CH=CH).  
13
C: 180.79 (C=O); 149.82 (C=N); 145.30 









H: 12.0 (1H, s, NH); 8.10 (1H, d, J = 16.2 Hz, 
CH=CH); 7.93 (1H, d, J = 16.2 Hz, CH=CH).  
13
C: 181.11 (C=O); 151.92 (C=N); 144.01 








H: 14 (1H, s, NH); 7.99 (1H, d, J = 15.6 Hz, 
CH=CH); 7.94 (1H, d, J = 15.6 Hz, CH=CH).  
13
C: 181.13 (C=O); 149.60 (C=N); 145.16 








H: 14 (1H, s, NH); 8.02 (1H, d, J = 15.6 Hz, 
CH=CH); 7.98 (1H, d, J = 15.6 Hz, CH=CH).  
13
C: 181.13 (C=O); 150.10 (C=N); 145.60 








H: 14 (1H, s, NH); 8.05 (1H, d, J = 15.6 Hz, 
CH=CH); 7.96 (1H, d, J = 15.6 Hz, CH=CH). 
13
C: 
181.18 (C=O); 150.60 (C=N); 145.20 (CH=CH); 









H: 13.54 (1H, s, NH); 8.30 (1H, d, J = 16 Hz, 
CH=CH); 8.10 (1H, d, J = 16 Hz, CH=CH). 
13
C: 
181.23 (C=O); 149.34 (C=N); 138.76 (CH=CH); 








1H: 13.54 (1H, s, NH); 8.30 (1H, d, J = 16 Hz, 
CH=CH); 8.12 (1H, d, J = 16 Hz, CH=CH).  
13C: 181.23 (C=O); 149.34 (C=N); 138.76 
(CH=CH); 121.49 (CH=CH). MS (m/z): 279 (M+1)
 
424.5 
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Table 1: Physicochemical data for characteristic groups and in vitro anthelmintic activity of compounds 6a-










C NMR of NH, -C=N, -CO-CH=CH- 









H: 13.54 (1H, s, N-H); 8.18 (1H, d, J = 16.4 
Hz, CH=CH); 8.08 (1H, d, J = 16.4 Hz, 
CH=CH).  
13
C: 181.23 (C=O); 149.34 (C=N); 138.76 











H: 13.48 (1H, s, NH); 8.25 (1H, d, J = 16.2 
Hz, CH=CH); 8.12 (1H, d, J = 16.2 Hz, 
CH=CH).  
13
C: 181.18 (C=O); 149.04 (C=N); 138.84 











H: 13.48 (1H, s, NH); 8.21 (1H, d, J = 16.2 
Hz, CH=CH); 8.12 (1H, d, J = 16.2 Hz, 
CH=CH).  
13
C: 181.18 (C=O); 149.04 (C=N); 138.84 










H: 12.0 (1H, s, NH); 8.10 (1H, d, J = 16.2 Hz, 
CH=CH); 7.93 (1H, d, J = 16.2 Hz, CH=CH).  
13
C: 180.61 (C=O); 149.07 (C=N); 144.51 









H: 14 (1H, s, NH); 7.99 (1H, d, J = 15 Hz, 
CH=CH); 7.95 (1H, d, J = 15 Hz, CH=CH).  
13
C: 180.71 (C=O); 148.95 (C=N); 142.29 











H: 14 (s, 1H, NH); 8.01 (1H, d, J = 15 Hz, 
CH=CH); 7.96 (1H, d, J = 15 Hz, CH=CH).  
13
C: 180.0 (C=O); 148.90 (C=N); 142.25 









H: 14 (1H, s, NH); 8.0 (1H, d, J = 15 Hz, 
CH=CH); 7.90 (1H, d, J = 15 Hz, CH=CH).  
13
C: 180.69 (C=O); 149.0 (C=N); 142.4 














H: 13.89 (s, 1H, NH); 8.06 (1H, d, J = 15.2 
Hz, CH=CH); 7.91 (1H, d, J = 15.2 Hz, 
CH=CH).  
13
C: 180.0 (C=O); 150.40 (C=N); 148.20 











H: 14 (1H, s, NH); 8.20 (1H, d, J = 16.2 Hz, 
CH=CH); 7.88 (1H, d, J = 16.2 Hz, CH=CH). 
13
C: 180.88 (C=O); 149.21 (C=N); 141.22 
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Table 1: Physicochemical data for characteristic groups and in vitro anthelmintic activity of compounds 6a-










C NMR of NH, -C=N  -CO-CH=CH- 








H: 14 (1H, s, N-H); 8.15 (1H, d, J = 16.2 Hz,, 
CH=CH); 7.88 (1H, d, J = 16.2 Hz, CH=CH). 
13
C: 
180.0 (C=O); 148.90 (C=N); 142.25 (CH=CH); 










H: 14 (1H, s, NH); 8.01 (1H, d, J = 15 Hz, 
CH=CH); 7.95 (1H, d, J = 15 Hz, CH=CH). 
13
C: 
179.91 (C=O); 149.40 (C=N); 142.50 (CH=CH); 










H: 14 (1H, s, NH); 8.01 (1H, d, J = 15 Hz, 
CH=CH); 7.91 (1H, d, J = 15 Hz, CH=CH). 
13
C: 
180.80 (C=O); 148.04 (C=N); 142.55 (CH=CH); 








H: 13.78 (1H, s, NH); 8.70 (1H, d, J = 16.3 Hz, 
CH=CH); 8.10 (1H, d, J = 16.2 Hz, CH=CH). 
13
C: 
182.86 (C=O); 151.31 (C=N); 145.39 (CH=CH); 











H: 13.82 (1H, s, NH); 8.70 (1H, d, J = 16.3 Hz, 
CH=CH); 8.10 (1H, d, J = 16.2 Hz, CH=CH). 
13
C: 
182.86 (C=O); 151.31 (C=N); 143.76 (CH=CH); 









H: 13.60 (1H,s, NH); 8.25 (1H, d, J = 16.2 Hz, 
CH=CH); 8.05 (1H, d, J = 16.2 Hz, CH=CH). 
13
C: 
182.13 (C=O); 150.09 (C=N); 144.27 (CH=CH); 








H: 13.92 (1H,s, NH); 8.71 (1H, d, J = 16.2 Hz, 
CH=CH); 7.97 (1H, d, J = 16.2 Hz, CH=CH). 
13
C: 
181.89 (C=O); 149.47 (C=N); 138.18 (CH=CH); 















standard chalcone (LC100 = 12.0 µg/ml). In 
addition, this compound had a nematicidal 
activity about 5 times higher than that of 
ivermectin (LC100 = 0.0092 µg/ml). However, 
the larvicidal action of 6a was less than 
fenbendazole (LC100 = 0.0005 µg/ml). 
Maintaining the benzimidazole ring doubled 
by introduction of group low electron donating 
such as methyl on the phenyl group (B) of our 
compound 6a (Figure 1), supports 
emergence of nematicidal activity. However, 
it seems to be related to isomeric position of 
methyl on phenyl group. The isomer para 
methyl 6d (LC100 = 0.16 µg/ml) had a 
larvicidal activity 18 times greater than that of 
isomer meta methyl 6c (LC100 = 2.87 µg/ml). 
This latter had an activity 4 times greater than 
ortho methyl 6b (LC100 = 12.0 µg/ml) which 
was equivalent to that of standard chalcone. 
However, none of these methylated isomers 
possessed nematicidal activity comparable to 
that of fenbendazole and ivermectin. 
Furthermore, replacement of methyl in para 
position by another alkyl group as isopropyl 
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(6e) with more lipophilicity, causes 
nematicidal activity loss (LC100 = 424.5 
µg/ml). Introduction on the phenyl group of 
compound 6a of another electron donating 
substituent, such as methoxy, has induced 
anti-haemonchus activity with the single 
isomer para methoxy 6k (LC100 = 0.68 µg/ml). 
This compound showed a nematicidal activity 
18 times greater than that of reference 
chalcone. Furthermore, duplication of 
methoxy group at positions 3 and 4 or 2 and 
5 (compounds 6l and 6m) caused the loss of 
nematicidal activity (LC100 = 424.5 µg/ml). It is 
the same for compounds mono-methoxylated 
in position ortho or meta (6i and 6j). Presence 
of halogen on phenyl group (B) induced 
anthelmintic properties according to the type 
of halogen. It was also dependent on the 
position of halogen on this phenyl group. 
Thus, the isomers ortho and the para 
brominated (6s and 6u), the meta chlorinated 
isomer (6q) and the isomer 2,4-dichloro (6r) 
have no larvicidal activity. By contrast, para 
chloro (6p) and para fluoro (6v) derivatives 
had their activities equivalent to that of 
reference chalcone (LC100 = 12.0 µg/ml). Only 
ortho chloro (6o) and meta bromo(6t) 
compounds (LC100 = 0.16 µg/ml) had 
nematicidal activities higher than that of the 
standard chalcone. Both compounds have 
equivalent activity to that of para methylated 
compound (6d). However, this action was low 
compared to that induced by ivermectin and 
fenbendazole. The modulation of phenyl ring 
by adding group strongly electron donating 
such as hydroxy, has induced nematicidal 
activity which depends on isomeric position of 
the group. Only the ortho and the meta 
hydroxylated compounds (6f and 6g) had 
anti-haemonchus concentrations better than 
that of standard chalcone. Moreover, this 
activity was enhanced when the hydroxy was 
in position meta on phenyl group (6g, LC100 = 
0.002 µg/ml). Compared with the nematicidal 
activities of our reference drugs, compound 
6g was 5 times more active than ivermectin, 
but lower than fenbendazole. The 
anthelmintic efficacy of 6g was however 
equivalent to the derivative none substituted 
(compound 6a). The presence of group more 
electron donating like dimethylamine at 
position para on the phenyl (6n), caused loss 
of nematicidal activities (LC100 = 424.5 µg/ml). 
Such a modulator would be unfavorable to 
the emergence of nematicidal activity. When 
we introduced entities that are strong electron 
repelling such as nitro on phenyl group, only 
the meta nitro isomer (6w; LC100 = 0.0092 
µg/ml) has induced anti-haemonchus activity 
equal to that of ivermectin. As for para nitro 
derivative (6x), it has not presented a good 
nematicidal activity (LC100 = 2.87 µg/ml). 
However, this compound remained more 
effective than our standard chalcone. The 
replacement of phenyl group by heteroaryl 
rings, such as 3-pyridinyl or 2-furyl, induced a 
contrasting anti-heamonchus activity. The 3-
pyridinyl derivative (6y) exalted anthelmintic 
properties compared to that of reference 
chalcone. However, this compound 
presented the same nematicidal action (LC100 
= 0.002 µg/ml) as that of the unsubstituted 
derivative (6a) and the meta hydroxylated 
derivative (6g). This substitution of phenyl by 
a 3-pyridinyl ring did not change the anti-
haemonchus activity. In contrary, the 2-furyl 
derivative (6z, LC100 = 2.87 µg/ml) did not 
increase nematicidal activity compared to that 
of compounds 6a, 6g, or 6y. It remained 1500 
times lower, even if it is more efficient than 
the standard chalcone. Compared to 
fenbendazole (benzimidazole anthelmintic 
drug), our hybrid benzimidazolyl-chalcones 
compounds (6a-z) were not substituted in 
their positions 5 and/or 6. However 
anthelmintic effectiveness of benzimidazole 
drugs would be based on blocking these sites 
of metabolism [17]. This structural difference 
may explain why these compounds were less 
active against Heamonchus than 
fenbendazole in vitro. This was not in itself a 
failure of our 8 active compounds (6a, 6d, 6g, 
6h, 6o, 6t, 6w, and 6y). Rather, it was a good 
prospect for their pharmacology modulation 
in position 5 (or 6) as in benzimidazole 
anthelmintic drugs. 
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CONCLUSION 
 
In this study, we designed, synthesized and 
evaluated the anthelmintic activity against 
Haemonchus contortus of 26 hybrid 
benzimidazolyl-chalcone compounds. Preli-
minary structure-activity relationship studies 
have helped to highlight structural elements 
of the nematicidal activities. These show that 
replacement of phenyl group in position 1 of 
1,3-diphenyl-2-propen-1-one by benzimi-
dazole ring induces the occurrence of a 
potential anthelmintic activity. This activity 
was also modulated by attaching different 
substituents on the phenyl group of 
benzimidazolyl-chalcones. The arylprope-
none group, like carbamate or thioalkyl in 
position 2 of benzimidazole ring, is a true 
anthelmintic pharmacophore. Our hybrid 
benzimidazolyl-chalcones are therefore 
promising candidates for the development of 
new anthelmintic agents substituted at 
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